Deep Life Medical
Deep Life Medical is a Deep Life Group company, registered in the UK and Portugal, ISO 9001:2015 and ISO 13485:2016 certified.

We have facilities in Sesimbra, Portugal - just south of Lisbon, in Edinburgh, Scotland, and Istanbul, Turkey, in addition to farms in Nigeria producing the raw materials for our drug development.

We operate an Environmental Management System which covers all our processes.

Our UK facility develops, manufactures and and licenses medical devices. Our Portugal facility, researches drugs for the treatment of sickle cell disease and osteoarthritis.

We are in the process of obtaining MDR certification for our Anugel(tm) products, which the Phase 2 Clinical Trial found to be an effective method of pain relief following haemorrhoid surgery, cutting down the need for anaelgesics.

We have a breakthrough treatment for arresting the symtoms in acute sickle cell disease, based on a compound identified in a traditional food supplement used on some regions of Nigeria. This completed its initial human trials in 2024 and we are scaling up for a Phase 3 double blind cross-over trial in 2025. We are planning a Phase 2 trial in 2025/26 to determine if the compound has benefits in the treatment of osteoarthritis or rheumatoid arthritis.

for contact, or write to us at:

Deep Life Medical Ltd
6 Newhailes Industrial Estate,
Musselburgh,
Scotland. EH21 6SY